Neuphoria Therapeutics Inc.
NEUPNasdaqCIK 1191070HealthcareFiscal year ends Jun 30
Reports and events: 91 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2308:00 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001213900-26-111863 |
| 2026-09-1820:33 ET | DEF 14A | Proxy statementPeriod 2026-11-02 | 0001140361-26-037139 |
| 2026-09-1820:10 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001193125-26-395536 |
| 2026-07-2422:37 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081052 |
| 2026-05-2620:15 ET | 8-K | 8.01 Other events | 0001213900-26-061028 |
| 2026-05-1512:33 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-225442 |
| 2026-02-1720:57 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001193125-26-054509 |
| 2026-01-0822:48 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-002245 |
| 2025-12-2921:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-004490 |
| 2025-12-1821:15 ET | 8-K | 3.01 Delisting notice | 0001213900-25-123289 |
| 2025-12-1721:01 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-122777 |
| 2025-12-0213:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-004208 |
| 2025-11-2814:09 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-004191 |
| 2025-11-1813:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-004110 |
| 2025-11-1412:34 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-281579 |
| 2025-11-1019:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-003859 |
| 2025-10-3000:04 ET | DEF 14A | Proxy statementPeriod 2025-12-09 | 0001140361-25-039748 |
| 2025-10-2720:19 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-102607 |
| 2025-10-2323:52 ET | SCHEDULE 13D | Ownership report, active investor | 0000902664-25-004537 |
| 2025-10-2020:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-100371 |
| 2025-09-2920:46 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001193125-25-223338 |
| 2025-09-1613:03 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-087950 |
| 2025-07-1821:00 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-065723 |
| 2025-05-2020:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-045970 |
| 2025-05-2020:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-075175 |
| 2025-02-1413:58 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0000950170-25-020473 |
| 2025-01-2821:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-009848 |
| 2025-01-1422:28 ET | 8-K | 8.01 Other events | 0001213900-25-003492 |
| 2024-12-2322:14 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-112016 |
| 2024-12-1621:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-109347 |
| 2024-12-1222:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-108436 |
| 2024-11-2121:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-100971 |
| 2024-11-1421:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-127032 |
| 2024-11-1221:06 ET | DEF 14A | Proxy statementPeriod 2024-12-11 | 0001213900-24-096782 |
| 2024-11-0821:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-095926 |
| 2024-10-1021:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-086918 |
| 2024-10-0722:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-233941 |
| 2024-10-0222:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-084175 |
| 2024-09-3010:38 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001213900-24-082909 |
| 2024-07-1610:30 ET | 8-K | 3.01 Delisting notice | 0001213900-24-061529 |
| 2024-06-0321:18 ET | 6-K | Report of a foreign private issuerPeriod 2024-06-03 | 0000950170-24-068125 |
| 2024-03-1510:06 ET | 6-K | Report of a foreign private issuerPeriod 2024-03-15 | 0000950170-24-031859 |
| 2024-01-0411:04 ET | 6-K | Report of a foreign private issuerPeriod 2024-01-04 | 0000950170-24-001476 |
| 2023-11-3011:02 ET | 6-K | Report of a foreign private issuerPeriod 2023-11-30 | 0000950170-23-066890 |
| 2023-11-2811:03 ET | 6-K | Report of a foreign private issuerPeriod 2023-11-28 | 0000950170-23-066236 |
| 2023-11-0310:03 ET | 6-K | Report of a foreign private issuerPeriod 2023-11-03 | 0000950170-23-058491 |
| 2023-10-1810:42 ET | 20-F | Annual report of a foreign private issuerPeriod 2023-06-30 | 0000950170-23-053873 |
| 2023-10-1610:03 ET | 6-K | Report of a foreign private issuerPeriod 2023-10-16 | 0000950170-23-053390 |
| 2023-09-2910:04 ET | 6-K | Report of a foreign private issuerPeriod 2023-09-29 | 0000950170-23-050573 |
| 2023-09-2811:00 ET | 6-K | Report of a foreign private issuerPeriod 2023-09-28 | 0000950170-23-050234 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.